Economic evaluation in stratified medicine: methodological issues and challenges
Background: Stratified Medicine (SM) is becoming a practical reality with the targeting of medicines by using a biomarker or genetic-based diagnostic to identify the eligible patient sub-population. Like any healthcare intervention, SM interventions have costs and consequences that must be considere...
Saved in:
Main Authors: | Hans-Joerg eFugel (Author), Mark eNuijten (Author), Maarten Jacobus Postma (Author), Ken eRedekop (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stratified Medicine and Reimbursement Issues
by: Hans-Joerg eFugel, et al.
Published: (2012) -
Cost-utility analysis: Current methodological issues and future perspectives
by: Mark J C Nuijten, et al.
Published: (2011) -
Microeconomic surplus in health care: Applied economic theory in health care in four European countries
by: Stefan eWalzer, et al.
Published: (2013) -
Health economic evaluation of gene replacement therapies: methodological issues and recommendations
by: Samuel Aballéa, et al.
Published: (2020) -
Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases
by: Carina Schey, et al.
Published: (2020)